Drugs / Domperidon
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT06171087 Comparator | Aug 2023 → Mar 2024 | — | German Institute of Human Nutrition | Unknown | No outcome recorded |
| — | NCT01218425 Background | Nov 2010 → Jun 2012 | — | Maastricht University Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Domperidon | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01218425 ↗ |
| Route | Oral | “All medications will be administered orally with a capsule.” NCT01218425 ↗ |